- Pharmaceutical Technology
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here
X

Merck to acquire oncology firm VelosBio for $2.75bn

Merck signs a definitive agreement to acquire VelosBio. Credit: Montgomery County Planning Commission.